AU5414479A - Antitumour composition - Google Patents
Antitumour compositionInfo
- Publication number
- AU5414479A AU5414479A AU54144/79A AU5414479A AU5414479A AU 5414479 A AU5414479 A AU 5414479A AU 54144/79 A AU54144/79 A AU 54144/79A AU 5414479 A AU5414479 A AU 5414479A AU 5414479 A AU5414479 A AU 5414479A
- Authority
- AU
- Australia
- Prior art keywords
- antitumour
- composition
- antitumour composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
- A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/813—Carrier is a saccharide
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16138878 | 1978-12-29 | ||
JP16138878A JPS5592325A (en) | 1978-12-29 | 1978-12-29 | Antitumor agent and its preparation |
JP14215379 | 1979-11-02 | ||
JP14215279 | 1979-11-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5414479A true AU5414479A (en) | 1980-07-03 |
AU518952B2 AU518952B2 (en) | 1981-10-29 |
Family
ID=15734135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54144/79A Ceased AU518952B2 (en) | 1978-12-29 | 1979-12-21 | Antitumour composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS5592325A (en) |
AU (1) | AU518952B2 (en) |
BE (1) | BE880970A (en) |
ZA (1) | ZA796896B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU545260B2 (en) * | 1982-07-06 | 1985-07-04 | Dow Chemical Company, The | Double l-shaped electrode for brine electrolysis cell |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5665828A (en) * | 1979-11-02 | 1981-06-03 | Kureha Chem Ind Co Ltd | Antitumor agent |
JPS58118520A (en) * | 1982-01-09 | 1983-07-14 | Hidematsu Hirai | Antitumor proteinic complex and preparation thereof |
JPH0651643B2 (en) * | 1983-01-19 | 1994-07-06 | 帝人株式会社 | Cell-killing modified immunoglobulin and method for producing the same |
JPH0611713B2 (en) * | 1983-04-08 | 1994-02-16 | 呉羽化学工業株式会社 | Human immunoglobulin-binding antitumor agent |
JPS6041617A (en) * | 1983-08-18 | 1985-03-05 | Teijin Ltd | Cytocidal modified immunoglobulin and its preparation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS162953B1 (en) * | 1972-05-10 | 1975-07-31 | ||
GB1509707A (en) * | 1974-09-20 | 1978-05-04 | Searle & Co | Immunological compounds |
IL47372A (en) * | 1975-05-27 | 1979-10-31 | Yeda Res & Dev | Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same |
-
1978
- 1978-12-29 JP JP16138878A patent/JPS5592325A/en active Granted
-
1979
- 1979-12-19 ZA ZA00796896A patent/ZA796896B/en unknown
- 1979-12-21 AU AU54144/79A patent/AU518952B2/en not_active Ceased
- 1979-12-28 BE BE6/47054A patent/BE880970A/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU545260B2 (en) * | 1982-07-06 | 1985-07-04 | Dow Chemical Company, The | Double l-shaped electrode for brine electrolysis cell |
Also Published As
Publication number | Publication date |
---|---|
ZA796896B (en) | 1980-11-26 |
BE880970A (en) | 1980-06-30 |
JPS6254086B2 (en) | 1987-11-13 |
JPS5592325A (en) | 1980-07-12 |
AU518952B2 (en) | 1981-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU528892B2 (en) | Polymer-polyol compositions | |
AU6146780A (en) | Rtv-silicone composition | |
AU4344579A (en) | Nitro-bromo-alkanol compositions | |
AU529553B2 (en) | Spraying composition | |
AU533436B2 (en) | Anti-diarrohoea composition | |
AU531882B2 (en) | Antiviral composition | |
AU5092779A (en) | Polycyclic cyanoketones | |
AU526954B2 (en) | Penicillin composition | |
AU5165479A (en) | Substituted 1-thia-3-aza-4-ones | |
AU530633B2 (en) | Glass composition | |
AU522764B2 (en) | Free-expandable rubbery composition | |
AU526595B2 (en) | Antiviral composition | |
AU519357B2 (en) | Substituted 2-phenylimino-imidazolidines | |
AU531541B2 (en) | Tickicidal composition | |
AU5399879A (en) | Substituted trifluoroethylamines | |
AU4559679A (en) | Anti-ulcer composition | |
AU535002B2 (en) | Phosphine-releasing composition | |
AU4678379A (en) | Substituted aklanyl-azolyl oxime-carbamates | |
AU518952B2 (en) | Antitumour composition | |
AU525223B2 (en) | Substituted n-acyl-amino-tetrahydro-2-furanones | |
AU529031B2 (en) | Cephalosporin composition | |
AU530738B2 (en) | Fasciolicidal compositions | |
AU525314B2 (en) | Peroxydicorbonate composition | |
AU523867B2 (en) | Substituted n-iminomethylpiperidines | |
AU542556B2 (en) | Composition |